Saroja Pharma Industries India Ltd vs Shankar Lal Rampal Dye Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 28.15 as of 23 Mar 15:30 . The P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 yearsThe P/E Ratio of Shankar Lal Rampal Dye-Chem Ltd changed from 5.9 on March 2021 to 31 on March 2025 . This represents a CAGR of 39.35% over 5 years The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 yearsThe Market Cap of Shankar Lal Rampal Dye-Chem Ltd changed from ₹ 44.83 crore on March 2021 to ₹ 353.1 crore on March 2025 . This represents a CAGR of 51.10% over 5 years The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shankar Lal Rampal Dye-Chem Ltd for the Dec '25 is ₹ 90.54 crore as compare to the Sep '25 revenue of ₹ 112.72 crore. This represent the decline of -19.68% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shankar Lal Rampal Dye-Chem Ltd for the Dec '25 is ₹ 2.67 crore as compare to the Sep '25 ebitda of ₹ 3.81 crore. This represent the decline of -29.92% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Shankar Lal Rampal Dye-Chem Ltd changed from ₹ 3.48 crore to ₹ 2.08 crore over 7 quarters. This represents a CAGR of -25.48% The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shankar Lal Rampal Dye-Chem Ltd changed from 1.4 % on March 2021 to 2.81 % on March 2025 . This represents a CAGR of 14.95% over 5 years .

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

About Shankar Lal Rampal Dye-Chem Ltd

Shankar Lal Rampal Dye-Chem Limited was originally constituted as a Private Limited Company in the name and styles of 'M/s.
Shankar Lal Rampal Dye-Chem Private Limited' vide an Incorporation Certificate on September 19, 2005.
Subsequently, it was converted into a Public Limited Company and the name of the Company was changed to 'Shankar Lal Rampal Dye-Chem Limited' vide a fresh Certificate of Incorporation dated May 08, 2018 issued by Registrar of Companies, Jaipur. The Company has made a prominent mark for itself in the Chemical industry, since its incorporation in 2005.
The Company's business in the trading of Dyes and Chemicals was started by Late Shree Shankar Lal Inani in 2005.
Based in Bhilwara (Rajasthan), the Company is named as a prominent Trader, Exporter, Importer, and Supplier of Sodium Sulphide flakes Red and Yellow, Soduim Hydro Sulphite , Hydrogen Peroxide, Citric Acid Monohydrate / Anhydrous, Phosphate Chemicals-sodium Hexameta phosphate, Sodium Tripoly phosphate, Tri Sodium Phosphate, Sodium Nitrite, and Refined Glycerine in India.

FAQs for the comparison of Saroja Pharma Industries India Ltd and Shankar Lal Rampal Dye-Chem Ltd

Which company has a larger market capitalization, Saroja Pharma Industries India Ltd or Shankar Lal Rampal Dye-Chem Ltd?

Market cap of Saroja Pharma Industries India Ltd is 11 Cr while Market cap of Shankar Lal Rampal Dye-Chem Ltd is 272 Cr

What are the key factors driving the stock performance of Saroja Pharma Industries India Ltd and Shankar Lal Rampal Dye-Chem Ltd?

The stock performance of Saroja Pharma Industries India Ltd and Shankar Lal Rampal Dye-Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Saroja Pharma Industries India Ltd and Shankar Lal Rampal Dye-Chem Ltd?

As of March 23, 2026, the Saroja Pharma Industries India Ltd stock price is INR ₹28.15. On the other hand, Shankar Lal Rampal Dye-Chem Ltd stock price is INR ₹42.63.

How do dividend payouts of Saroja Pharma Industries India Ltd and Shankar Lal Rampal Dye-Chem Ltd compare?

To compare the dividend payouts of Saroja Pharma Industries India Ltd and Shankar Lal Rampal Dye-Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.